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ABSTRACT
Accurate Computer-Assisted Diagnosis, associated with proper data
wrangling, can alleviate the risk of overlooking the diagnosis in a
clinical environment. Towards this, as a Data Augmentation (DA)
technique, Generative Adversarial Networks (GANs) can synthesize
additional training data to handle the small/fragmented medical
imaging datasets collected from various scanners; those images
are realistic but completely different from the original ones, filling
the data lack in the real image distribution. However, we cannot
easily use them to locate disease areas, considering expert physi-
cians’ expensive annotation cost. Therefore, this paper proposes
Conditional Progressive Growing of GANs (CPGGANs), incorpo-
rating highly-rough bounding box conditions incrementally into
PGGANs to place brain metastases at desired positions/sizes on
256×256Magnetic Resonance (MR) images, for Convolutional Neu-
ral Network-based tumor detection; this first GAN-based medical
DA using automatic bounding box annotation improves the training
robustness. The results show that CPGGAN-based DA can boost
10% sensitivity in diagnosis with clinically acceptable additional
False Positives. Surprisingly, further tumor realism, achieved with
additional normal brain MR images for CPGGAN training, does not
contribute to detection performance, while even three physicians
cannot accurately distinguish them from the real ones in Visual
Turing Test.
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1 INTRODUCTION
Accurate Computer-Assisted Diagnosis (CAD) with high sensitiv-
ity can alleviate the risk of overlooking the diagnosis in a clinical
environment. Specifically, Convolutional Neural Networks (CNNs)
have revolutionized medical imaging, such as diabetic eye disease
diagnosis [9], mainly thanks to large-scale annotated training data.
However, obtaining such annotated medical big data is demand-
ing; thus, better diagnosis requires intensive Data Augmentation
(DA) techniques, such as geometric/intensity transformations of
original images [23, 29]. Yet, those augmented images intrinsically
have a similar distribution to the original ones, leading to limited
performance improvement; in this context, Generative Adversarial
Network (GAN) [7]-based DA can boost the performance by filling
the real image distribution uncovered by the original dataset, since
it generates realistic but completely new samples showing good
generalization ability; GANs achieved outstanding performance
in computer vision, including 21% performance improvement in
eye-gaze estimation [33].
Also in medical imaging, where the primary problem lies in
small and fragmented imaging datasets from various scanners [30],
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Figure 1: CPGGAN-based DA for better tumor detection:
our CPGGANs generates a number of realistic/diverse brain
MR images with tumors at desired positions/sizes based on
bounding boxes, and the object detector uses them as addi-
tional training data.
GAN-based DA performs effectively: researchers improved classifi-
cation by augmentation with noise-to-image GANs (e.g., random
noise samples to diverse pathological images) [6] and segmentation
with image-to-image GANs (e.g., a benign image with a pathology-
conditioning image to a malignant one) [15, 32]. Such applications
include 256 × 256 brain Magnetic Resonance (MR) image genera-
tion for tumor/non-tumor classification [11]. Nevertheless, unlike
bounding box-based object detection, simple classification cannot
locate disease areas and rigorous segmentation requires physicians’
expensive annotation.
So, how can we achieve high sensitivity in diagnosis using GANs
with minimum annotation cost, based on highly-rough and incon-
sistent bounding boxes? As an advanced data wrangling approach,
we aim to generate GAN-based realistic and diverse 256× 256 brain
MR images with brain metastases at desired positions/sizes for ac-
curate CNN-based tumor detection; this is clinically valuable for
better diagnosis, prognosis, and treatment, since brain metastases
are the most common intra-cranial tumors, getting prevalent as
oncological therapies improve cancer patients’ survival [2]. Con-
ventional GANs cannot generate realistic 256×256whole brain MR
images conditioned on tumor positions/sizes under limited training
data/highly-rough annotation [11]; since noise-to-image GANs can-
not directly be conditioned on an image describing desired objects,
we have to use image-to-image GANs (e.g., input both the condi-
tioning image/random noise samples or the conditioning image
alone with dropout noises [34] on a generator [14])—it results in
unrealistic high-resolution MR images with odd artifacts due to
the limited training data/rough annotation, tumor variations, and
strong consistency in brain anatomy, unless we also input a benign
image sacrificing image diversity.
Such a high-resolution whole image generation approach, not
involving Regions of Interest (ROIs) alone, however, could facilitate
detection because it provides more image details and most CNN
architectures adopt around 256 × 256 input pixels. Therefore, as a
conditional noise-to-image GAN not relying on an input benign
image, we propose Conditional Progressive Growing of GANs (CPG-
GANs), incorporating highly-rough bounding box conditions incre-
mentally into PGGANs [16] to naturally place tumors of random
shape at desired positions/sizes on MR images. Moreover, we eval-
uate the generated images’ realism via Visual Turing Test [31] by
three expert physicians, and visualize the data distribution via the t-
Distributed Stochastic Neighbor Embedding (t-SNE) algorithm [35].
Using the synthetic images, our novel CPGGAN-based DA boosts
10% sensitivity in diagnosis with clinically acceptable additional
False Positives (FPs). Surprisingly, we confirm that further realistic
tumor appearance, judged by the physicians, does not contribute
to detection performance.
Research Questions.We mainly address two questions:
• PGGAN Conditioning: How can we modify PGGANs to
naturally place objects of random shape, unlike rigorous
segmentation, at desired positions/sizes based on highly-
rough bounding box masks?
• Medical Data Augmentation: How can we balance the
number of real and additional synthetic training data to
achieve the best detection performance?
Contributions. Our main contributions are as follows:
• Conditional Image Generation: As the first bounding
box-based 256×256whole pathological image generation ap-
proach, CPGGANs can generate realistic/diverse imageswith
objects naturally at desired positions/sizes; the generated
images can play a vital role in clinical oncology applications,
such as DA, data anonymization, and physician training.
• Misdiagnosis Prevention: This study allows us to achieve
high sensitivity in automatic CAD using small/fragmented
medical imaging datasets with minimum annotation efforts
based on highly-rough/inconsistent bounding boxes.
• BrainMetastasesDetection:This first bounding box-based
brain metastases detection method successfully detects tu-
mors exploiting CPGGAN-based DA.
2 GENERATIVE ADVERSARIAL NETWORKS
In terms of realism and diversity, GANs [7] have shown great
promise in image generation [17, 20] through a two-player minimax
game. However, the two-player objective function triggers diffi-
cult training, accompanying artifacts and mode collapse [8] when
generating high-resolution images, such as 256 × 256 ones [25];
to tackle this, multi-stage generative training methods have been
proposed: AttnGAN uses attention-driven multi-stage refinement
for fine-grained text-to-image generation [37]; PGGANs adopts
incremental training procedures from low to high resolution for
generating a realistic image [16]. Moreover, GAN-based 128 × 128
conditional image synthesis using a bounding box can control gen-
erated images’ local properties [27]. GANs can typically generate
more realistic images than other common deep generative models,
such as variational autoencoders [19] suffering from the injected
noise and imperfect reconstruction due to a single objective func-
tion [22]; thus, as a DA technique, most researchers chose GANs
for facilitating classification [1, 21], object detection [12, 24], and
segmentation [38] to tackle the lack of training data.
This GAN-based DA trend especially applies to medical imag-
ing for handling various types of small/fragmented datasets from
multiple scanners: researchers used noise-to-image GANs for im-
proving classification on brain tumor/non-tumor MR [11] and liver
lesion Computed Tomography (CT) images [6]; others used image-
to-image GANs focusing on ROI (i.e., small pathological areas) for
improving segmentation on 3D brain tumor MR [32] and 3D lung
nodule CT images [15].
However, to the best of our knowledge, our work is the first
GAN-based medical DA method using automatic bounding box
annotation, despite 2D bounding boxes’ cheap annotation cost com-
pared with rigorous 3D segmentation. Moreover, unlike the ROI
DA work generating only pedestrians without the background for
pedestrian detection [24], this is the first GAN-based whole im-
age augmentation approach including the background, relying on
bounding boxes, in computer vision. Along with classic transforma-
tions of real images, a completely different approach—generating
novel whole 256×256 brain MR images with tumors at desired posi-
tions/sizes using CPGGANs—may become a clinical breakthrough
in terms of annotation cost.
3 MATERIALS AND METHODS
3.1 Brain Metastases Dataset
As a new dataset for the first bounding box-based brain metas-
tases detection, this paper uses a dataset of contrast-enhanced
T1-weighted (T1c) brain axial MR images, collected by the authors
(National Center for Global Health and Medicine, Tokyo, Japan) and
currently not publicly available for ethical restrictions; for robust
clinical applications, it contains 180 brain metastatic cancer cases
from multiple MRI scanners—those images differ in contrast, mag-
netic field strength (i.e., 1.5 T, 3.0 T), and matrix size (i.e., 190× 224,
216 × 256, 256 × 256, 460 × 460 pixels). In the clinical practice, T1c
MRI is well-established in brain metastases detection thanks to
its high-contrast in the enhancing region. We also use additional
brain MR images from 193 normal subjects only for CPGGAN train-
ing, not in tumor detection, to confirm the effect of combining the
normal and pathological images for training.
3.2 CPGGAN-based Image Generation
Data Preparation For tumor detection, ourwhole brainmetastases
dataset (180 patients) is divided into: (i) a training set (126 patients);
(ii) a validation set (18 patients); (iii) a test set (36 patients); only the
training set is used for GAN training to be fair. Our experimental
dataset consists of:
• Training set (2, 813 images/5, 963 bounding boxes);
• Validation set (337 images/616 bounding boxes);
• Test set (947 images/3, 094 bounding boxes).
Our training set is relatively small/fragmented for CNN-based
applications, considering that the same patient’s tumor slices could
convey very similar information. To confirm the effect of realism
and diversity—provided by combining PGGANs and bounding box
conditioning—on tumor detection, we compare the following GANs:
(i) CPGGANs trained only with the brain metastases images; (ii)
CPGGANs trained also with additional 16, 962 brain images from
193 normal subjects; (iii) Image-to-image GAN trained only with
256 × 256 Real tumor
256 × 256 Highly-Rough Annotation
32 × 32 Real Tumor Bbox
256 × 256 Real Non-tumor
Figure 2: Example real 256 × 256 MR images with highly-
rough annotation used for GAN training and resized 32 × 32
tumor bounding boxes.
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Figure 3: Proposed CPGGAN architecture for synthetic 256×
256 MR image generation with tumors at desired posi-
tions/sizes based on bounding boxes.
the brain metastases images. After skull-stripping on all images
with various resolution, remaining brain parts are cropped and re-
sized to 256 × 256 pixels (i.e., a power of 2 for better GAN training).
As Fig. 2 shows, we lazily annotate tumors with highly-rough and
inconsistent bounding boxes to minimize expert physicians’ labor.
CPGGANs is a novel conditional noise-to-image training method
for GANs, incorporating highly-rough bounding box conditions in-
crementally into PGGANs [16], unlike conditional image-to-image
GANs requiring rigorous segmentation masks [3]. The original
PGGANs exploits a progressively growing generator and discrimi-
nator: starting from low-resolution, newly-added layers model fine-
grained details as training progresses. As Fig. 3 shows, we further
condition the generator and discriminator to generate realistic and
diverse 256× 256 brain MR images with tumors of random shape at
desired positions/sizes using only bounding boxes without an input
benign image under limited training data/highly-rough annotation.
Our modifications to the original PGGANs are as follows:
• Conditioning image: prepare a 256 × 256 black image (i.e.,
pixel value: 0) with white bounding boxes (i.e., pixel value:
255) describing tumor positions/sizes for attention;
• Generator input: resize the conditioning image to the previ-
ous generator’s output resolution/channel size and concate-
nate them (noise samples generate the first 4 × 4 images);
• Discriminator input: concatenate the conditioning image
with a real or synthetic image.
CPGGAN Implementation DetailsWe use the CPGGAN archi-
tecture with the Wasserstein loss using gradient penalty [8]:
E
y˜∼Pд
[D(y˜)] − E
y∼Pr
[D(y)] + λ E
yˆ∼Pyˆ
[(∇yˆD(yˆ)2 − 1)2] (1)
where the discriminator D belongs to the set of 1-Lipschitz func-
tions, Pr is the data distribution by the true data sample y, and Pд
is the model distribution by the synthetic sample y˜ generated from
the conditioning image noise samples using uniform distribution
in [−1, 1]. The last term is gradient penalty for the random sample
yˆ ∼ Pyˆ .
Training lasts for 3, 000, 000 steps with a batch size of 4 and
2.0×10−4 learning rate for the Adam optimizer [18]. We flip the dis-
criminator’s real/synthetic labels once in three times for robustness.
During testing, as tumor attention images, we use the annotation of
training images with a random combination of horizontal/vertical
flipping, width/height shift up to 10%, and zooming up to 10%; these
CPGGAN-generated images are used as additional training images
for tumor detection.
Image-to-imageGAN is a conventional conditional GAN that gen-
erates brain MR images with tumors, concatenating a 256×256 con-
ditioning image with noise samples for a generator input and con-
catenating the conditioning image with a real/synthetic image for a
discriminator input, respectively. It uses a U-Net-like [29] generator
with 4 convolutional/deconvolutional layers in encoders/decoders
respectively with skip connections, along with a discriminator with
3 decoders. We apply batch normalization [13] to both convolution
with LeakyReLU and deconvolution with ReLU. It follows the same
implementation details as for the CPGGANs.
3.3 YOLOv3-based Brain Metastases Detection
You Only Look Once v3 (YOLOv3) [26] is a fast and accurate
CNN-based object detector: unlike conventional classifier-based
detectors, it divides the image into regions and predicts bounding
boxes/probabilities for each region. We adopt YOLOv3 to detect
brain metastases on MR images since its high efficiency can play
a clinical role in real-time tumor alert; moreover, it shows very
comparable results with 608× 608 network resolution against other
state-of-the-art detectors, such as Faster RCNN [28].
To confirm the effect of GAN-based DA, the following detec-
tion results are compared: (i) 2, 813 real images without DA, (ii),
(iii), (iv) with 4, 000/8, 000/12, 000 CPGGAN-based DA, (v), (vi), (vii)
with 4, 000/8, 000/12, 000 CPGGAN-based DA, trained with addi-
tional normal brain images, (viii), (ix), (x) with 4, 000/8, 000/12, 000
image-to-image GAN-based DA. Due to the risk of overlooking
the diagnosis via medical imaging, higher sensitivity matters more
than less FPs; thus, we aim to achieve higher sensitivity with a
clinically acceptable number of FPs, adding the additional synthetic
training images. Since our annotation is highly-rough, we calculate
sensitivity/FPs per slice with both Intersection over Union (IoU)
threshold 0.5 and 0.25. For better DA, GAN-generated images with
unclear tumor appearance are manually discarded.
YOLOv3 Implementation DetailsWe use the YOLOv3 architec-
ture with Darknet-53 as a backbone classifier and sum squared
error between the predictions/ground truth as a loss:
λcoord
S2∑
i=0
B∑
j=0
1
obj
i j
[(xi − xˆi )2 + (yi − yˆi )2]
+ λcoord
S2∑
i=0
B∑
j=0
1
obj
i j
[(√
wi −
√
wˆi
)2
+
(√
hi −
√
hˆi
)2]
+
∑S2
i=0
∑B
j=0 1
obj
i j (Ci − Cˆi )2 + λnoobj
∑S2
i=0
∑B
j=0 1
noobj
i j (Ci − Cˆi )2
+
S2∑
i=0
1
obj
i
∑
c ∈classes
(pi (c) − pˆi (c))2 (2)
where xi ,yi are the centroid location of an anchor box,wi ,hi are
the width/height of the anchor,Ci is the Objectness (i.e., confidence
score of whether an object exists), and pi (c) is the classification
loss. Let S2 and B be the size of a feature map and the number of
anchor boxes, respectively. 1obji is 1 when an object exists in cell i
and otherwise 0.
During training, we use a batch size of 64 and 1.0 × 10−3 learn-
ing rate for the Adam optimizer. The network resolution is set
to 416 × 416 pixels during training and 608 × 608 pixels during
validation/testing respectively to detect small tumors better. We
recalculate the anchors at each DA setup. As classic DA, geomet-
ric/intensity transformations are also applied to both real/synthetic
images during training to achieve the best performance. For test-
ing, we pick the model with the best sensitivity on validation with
detection threshold 0.1%/IoU threshold 0.5 between 96, 000-240, 000
steps to avoid severe FPs while achieving high sensitivity.
3.4 Clinical Validation via Visual Turing Test
To quantitatively evaluate how realistic the CPGGAN-based syn-
thetic images are, we supply, in random order, to three expert
physicians a random selection of 50 real and 50 synthetic brain
metastases images. They take four tests in ascending order: (i), (ii)
test 1, 2: real vs CPGGAN-generated resized 32 × 32 tumor bound-
ing boxes, trained without/with additional normal brain images;
(iii), (iv) test 3, 4: real vs CPGGAN-generated 256 × 256MR images,
trained without/with additional normal brain images.
Then, the physicians are asked to constantly classify them as
real/synthetic, if needed, zooming/rotating them, without previous
training stages revealing which is real/synthetic. Such Visual Turing
Table 1: YOLOv3 brain metastases detection results with/without DA, using bounding boxes with detection threshold 0.1%.
IoU ≥ 0.5 IoU ≥ 0.25
Sensitivity FPs per slice Sensitivity FPs per slice
2,813 real images 0.67 4.11 0.83 3.59
+ 4,000 CPGGAN-based DA 0.77 7.64 0.91 7.18
+ 8,000 CPGGAN-based DA 0.71 6.36 0.87 5.85
+ 12,000 CPGGAN-based DA 0.76 11.77 0.91 11.29
+ 4,000 CPGGAN-based DA (+ normal) 0.69 7.16 0.86 6.60
+ 8,000 CPGGAN-based DA (+ normal) 0.73 8.10 0.89 7.59
+ 12,000 CPGGAN-based DA (+ normal) 0.74 9.42 0.89 8.95
+ 4,000 Image-to-Image GAN-based DA 0.72 6.21 0.87 5.70
+ 8,000 Image-to-Image GAN-based DA 0.68 3.50 0.84 2.99
+ 12,000 Image-to-Image GAN-based DA 0.74 7.20 0.89 6.72
Test [31] can probe the human ability to identify attributes/relationships
in images, also in evaluatingGAN-generated images’ appearance [33].
This similarly applies to medical images in a clinical environment,
wherein physicians’ specialty is critical [6, 10].
3.5 Visualization via t-SNE
To visually analyze the distribution of real/synthetic images, we
use t-SNE [35] on a random selection of:
• 500 real tumor images;
• 500 CPGGAN-generated tumor images;
• 500 CPGGAN-generated tumor images, trained with addi-
tional normal brain images.
We normalize the input images to [0, 1].
T-SNE is a machine learning algorithm for dimensionality reduc-
tion to represent high-dimensional data into a lower-dimensional
(2D/3D) space. It non-linearly adapts to input data using perplexity
to balance between the data’s local and global aspects.
t-SNE Implementation DetailsWe use t-SNE with a perplexity
of 100 for 1, 000 iterations to get a 2D representation.
4 RESULTS
This section shows howCPGGANs and image-to-image GAN gener-
ate brain MR images. The results include instances of synthetic im-
ages and their influence on tumor detection, along with CPGGAN-
generated images’ evaluation via Visual Turing Test and t-SNE.
4.1 MR Images Generated by CPGGANs
Fig. 4 illustrates example GAN-generated images. CPGGANs suc-
cessfully captures the T1c-specific texture and tumor appearance at
desired positions/sizes. Since we use highly-rough bounding boxes,
the synthetic tumor shape largely varies within the boxes. When
trained with additional normal brain images, it clearly maintains
the realism of the original images with less odd artifacts, including
tumor bounding boxes, which the additional images do not include.
However, as expected, image-to-image GAN, without progressive
growing, generates clearly unrealistic images without an input
benign image due to the limited training data/rough annotation.
256 × 256 CPGGAN-generated Tumor w/o Normal
32 × 32 CPGGAN-generated Tumor Bbox w/o Normal
256 × 256 CPGGAN-generated Tumor w/ Normal
32 × 32 CPGGAN-generated Tumor Bbox w/ Normal
256 × 256 Image-to-Image GAN-generated Tumor w/o Normal
32 × 32 Image-to-Image GAN-generated Tumor Bbox w/o Normal
Figure 4: Example synthetic 256 × 256 MR images and re-
sized 32 × 32 tumor bounding boxes yielded by (a), (b) CPG-
GANs trainedwithout/with additional normal brain images;
(c) image-to-image GAN trained without normal images.
4.2 Brain Metastases Detection Results
Table 1 shows the tumor detection results with/without GAN-based
DA. As expected, the sensitivity remarkably increases with the
additional synthetic training data while FPs per slice also increase.
Ground Truth w/o GAN 4k GAN 8k GAN 12k GAN 4k GAN+Normal 8k GAN+Normal 12k GAN+Normal
Figure 5: Example detection results obtained by the seven DA setups on four different images, compared against the ground
truth: (a) ground truth; (b) without CPGGAN-based DA; (c), (d), (e) with 4k/8k/12kCPGGAN-based DA; (f), (g), (h) with 4k/8k/12k
CPGGAN-based DA, trained with additional normal brain images. Red V symbols indicate the brain metastases undetected
without CPGGAN-based DA, but detected with 4k CPGGAN-based DA.
Adding more synthetic images generally leads to a higher amount
of FPs, also detecting blood vessels that are small/hyper-intense on
T1c MR images, very similarly to the enhanced tumor regions (i.e.,
the contrast agent perfuses throughout the blood vessels). How-
ever, surprisingly, adding only 4, 000 CPGGAN-generated images
achieves the best sensitivity improvement by 0.10 with IoU thresh-
old 0.5 and by 0.08 with IoU threshold 0.25, probably due to the
real/synthetic training image balance—the improved training ro-
bustness achieves sensitivity 0.91with moderate IoU threshold 0.25
despite our highly-rough bounding box annotation.
Fig. 5 also visually indicates that it can alleviate the risk of over-
looking the tumor diagnosis with clinically acceptable FPs; in the
clinical routine, the bounding boxes, highly-overlapping around
tumors, only require a physician’s single check by switching on/off
transparent alpha-blended annotation on MR images. It should be
noted that we cannot increase FPs to achieve such high sensitiv-
ity without CPGGAN-based DA. Moreover, our results reveal that
further realism—associated with the additional normal brain im-
ages during training—does not contribute to detection performance,
possibly as the training focuses less on tumor generation. Image-
to-image GAN-based DA just moderately facilitates detection with
less additional FPs, probably because the synthetic images have
a distribution far from the real ones and thus their influence on
detection is limited during testing.
4.3 Visual Turing Test Results
Table 2 shows the confusion matrix for the Visual Turing Test. The
expert physicians easily recognize 256×256 synthetic images due to
the lack of training data. However, when CPGGANs is trained with
additional normal brain images, the experts classify a considerable
number of synthetic tumor bounding boxes as real; it implies that
the additional normal images remarkably facilitate the realism of
both healthy and pathological brain parts while they do not include
abnormality; thus, CPGGANs might perform as a tool to train
medical students and radiology trainees when enough medical
images are unavailable, such as abnormalities at rare positions/sizes.
Such GAN applications are clinically prospective [5], considering
the expert physicians’ positive comments about the tumor realism.
4.4 T-SNE Results
As presented in Fig. 6, synthetic tumor bounding boxes have a mod-
erately similar distribution to real ones, but they also fill the real
image distribution uncovered by the original dataset, implying their
effective DA performance; especially, the CPGGAN-generated im-
ages trained without normal brain images distribute wider than the
center-concentrating images trained with the normal brain images.
Meanwhile, real/synthetic whole brain images clearly distribute dif-
ferently, due to the real MR images’ strong anatomical consistency
(Fig. 7). Considering the achieved high DA performance, the tumor
(i.e., ROI) realism/diversity matter more than the whole image re-
alism/diversity, since YOLOv3 look at an image patch instead of a
whole image, similarly to most other CNN-based object detectors.
Table 2: Visual Turing Test results by three physicians for classifying real vs CPGGAN-generated images: (a), (b) Test 1, 2:
resized 32 × 32 tumor bounding boxes, trained without/with additional normal brain images; (c), (d) Test 3, 4: 256 × 256 MR
images, trained without/with normal brain images. Accuracy denotes the physicians’ successful classification ratio between
the real/synthetic images.
Accuracy Real Selected as Real Real as Synt Synt as Real Synt as Synt
Test1
Physician1 88% 40 10 2 48
Physician2 95% 45 5 0 50
Physician3 97% 49 1 2 48
Test2
Physician1 81% 39 11 8 42
Physician2 83% 43 7 10 40
Physician3 91% 45 5 4 46
Test3
Physician1 97% 47 3 0 50
Physician2 96% 46 4 0 50
Physician3 100% 50 0 0 50
Test4
Physician1 91% 41 9 0 50
Physician2 96% 48 2 2 48
Physician3 100% 50 0 0 50
Figure 6: T-SNE results with 500 32× 32 resized tumor bound-
ing box images per each category: (a) Real tumor images; (b),
(c) CPGGAN-generated tumor images, trained without/with
additional normal brain images.
5 CONCLUSION
Without relying on an input benign image, our CPGGANs can
generate realistic and diverse 256 × 256 MR images with brain
metastases of random shape, unlike rigorous segmentation, nat-
urally at desired positions/sizes, and achieve high sensitivity in
tumor detection—even with small/fragmented training data from
multiple MRI scanners and lazy annotation using highly-rough
bounding boxes; in the context of intelligent data wrangling, this
attributes to the CPGGANs’ good generalization ability to incre-
mentally synthesize conditional whole images with the real image
Figure 7: T-SNE results with 500 256×256 images per each cat-
egory: (a) Real tumor images; (b), (c) CPGGAN-generated tu-
mor images, trained without/with additional normal brain
images.
distribution unfilled by the original dataset, improving the training
robustness.
We confirm that the realism and diversity of the generated im-
ages, judged by three expert physicians via Visual Turing Test,
do not imply better detection performance; as the t-SNE results
show, the CPGGAN-generated images, trained with additional
non-tumor normal images, lack diversity probably because the
training less focuses on tumors. Moreover, we notice that adding
over-sufficient synthetic images leads to more FPs, but not always
higher sensitivity, possibly due to the training data imbalance
between real and synthetic images; as the t-SNE results reveal,
the CPGGAN-generated tumor bonding boxes have a moderately
similar—mutually complementary—distribution to the real ones;
thus, GAN-overwhelming training images may decrease the neces-
sary influence of the real samples and harm training, rather than
providing robustness. Lastly, image-to-image GAN-based DA just
moderately facilitates detection with less additional FPs, proba-
bly due to the lack of realism. However, further investigations are
needed to maximize the effect of the CPGGAN-based medical image
augmentation.
For example, we could verify the effect of further realism in
return for less diversity by combining ℓ1 loss with the Wasserstein
loss using gradient penalty for GAN training. We can also combine
those CPGGAN-generated images, trained without/with additional
brain images, similarly to ensemble learning [4]. Lastly, we plan to
define a newGAN loss function that directly optimizes the detection
results, instead of realism, similarly to the three-player GAN for
optimizing classification results [36].
Overall, minimizing expert physicians’ annotation efforts, our
novel CPGGAN-based DA approach sheds light on diagnostic and
prognostic medical applications, not limited to brain metastases
detection; future studies, especially on 3D bounding box detection
with highly-rough annotation, are required to extend our promising
results. Along with the DA, the CPGGANs has other potential clini-
cal applications in oncology: (i) A data anonymization tool to share
patients’ data outside their institution for training while preserving
detection performance. Such a GAN-based application is reported
in Shin et al. [32]; (ii) A physician training tool to display random
synthetic medical images with abnormalities at both common and
rare positions/sizes, by training CPGGANs on highly unbalanced
medical datasets (i.e., limited pathological and abundant normal
samples, respectively). It can help train medical students and radi-
ology trainees despite infrastructural and legal constraints [5].
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